(Upd EU/Be)Treatment Guidelines COVID19,Azithromycin+Chloroquine,ACE/ARBs Switch

This shows the updated (March 19) official Belgian treatment guidelines for COVID19 and comparison with treatment guidelines for France,Belgium,Switzerland,Netherlands.

Notably it shows now the addition of Azithromicyn as an addition to Chloroquine/Hydroxichloroquine (cf the controversial French study source: https://www.mediterranee-infection.com/wp-content/uploads/20...).

It's also clearly indicated that Remdesivir is now in short supply: " At this moment very restricted availability of remdesivir (long delay for supply) and very strict criteria released by Gilead "

France is still not considering hydroxichloroquine/chloroquine at this point officially for some strange reason.

Also this line seems important : " Lopinavir/ritonavir can still be therefore considered a second choice for the moment, when hydroxychloroquine is contraindicated, but only if this treatment could be administered early in the course of the disease (within 10 days after symptoms onset). We consider this treatment as futile if administered later "

So they seem to think Lopinavir/ritonavir is futile is not administered early.

And last but not least and in line with several hackernews threads. They do seem to somewhat advice physicians to possibly switch medications of infected patients with High Blood Pressure and ACE inhibitors/ARBs to an equivalent therapy.